Infectious Bronchitis: Key points about vaccination - The Poultry Site

Introduction

Infectious Bronchitis is a major disease with a global presence which causes different challenges. Infectious Bronchitis is caused by the Avian Coronavirus. The virus is classified into different Genotypes, but the Genotype classification does not give us the full picture. Another classification is the serotype, as the serotype is the reaction between a specific antibody and a virus strain, but the serotype does not provide a complete immunological classification either, as different serotypes do not have full cross-protection between them. The variation of IBV serotypes is related to the variation of the S protein (Cavanagh, 1998), however nor does this provide the complete profile of the virus, as there is partial cross-protection between the different serotypes. The most widely used classification method is the protectotype (immunotype). The protectotype is the combination of different serotypes of the virus providing a broader protection than just the serotype vaccinated.

The clinical signs of infectious bronchitis can vary, from respiratory symptoms to nephritis, poor egg production, poor egg quality etc., as there is a variety of tissue trophism in the different IB strains, normally the systems that are mainly affected are respiratory, reproductive and renal. The clinical signs are not pathognomonic, so there is not one single symptom that can identify the disease. In order to have a diagnosis, the clinical signs have to be analysed in combination with laboratory results.

The history of Infectious Bronchitis started in 1931 with an "apparently new respiratory disease in chickens" (Schalk, A. E, and M. C. Hawn, 1931), and in the same year some papers also described LT as Infectious Bronchitis (Fabricant, J, 1998). Those early findings were related to the respiratory tract leading to a secondary infection. The Connecticut variant was isolated in 1951 (De Wit, 2011), and did not cross-neutralize or cross-protect with the Original Massachusetts isolate. The first IB isolate in the Netherlands was in 1956, this virus isolate was used, through a number of passages in embryonated eggs, initially 52, to develop the first vaccine. This first strain was isolated on a farm named Hyuben (H), and the vaccine with 52 passages, H52. Different vaccines have been developed from this first vaccine up to now, H120, cloned Massachusetts vaccines and different variants depending on the region.

Basics about IB vaccination

The first step in order to have an efficient vaccination programme is to know the strains present in the region. The IB diagnosis can be done using serology and molecular diagnostics. The limitation with serology is that the IB strain is antigen-specific, so you need to know the different virus strains present to test, the serology normally available is the Massachusetts type.

The molecular diagnosis, PCR and sequencing, is normally based on the amplification of the partial sequence of the S1 (Spike) gene (Cavanagh et al. 1999). The IB genotypes circulating will vary depending on the region. In Europe the most important strains are the 793/B, the Dutch isolates D207, D212, 03128, D3896 and D3128, in Asia, 793B and QX, Brazil the BR, the USA, Connecticut (Conn), Arkansas (Ark) and Georgia 98 (GA98) (Sjaak et al, 2011). Most of those different genotypes have partial or no cross-protection between them.

The protectotype concept is the use of two vaccines against three strains, which is key to having broader protection and to controlling the IB strains for which there is no commercially available vaccine. The presence of the Massachusetts strains is included in almost all vaccination strategies.

Considerations concerning th einfectious bronchitis vaccination programme

  • It is important to know the different IB genotypes in the region in order to have an accurate diagnosis.
  • As there is genetic diversity in Infectious Bronchitis, if there is no commercial vaccine for the strain present, it is important to assess whether a combination of commercially available vaccines provides some protection (Protectotype) against it.
  • The Massachusetts strain is present in almost all IB vaccination programmes, as this strain is present worldwide. Normally the ideal vaccination route for live IB vaccines is spray or eyedrop, if necessary, drinking water vaccination, following all the vaccination procedures, such as drinking water temperature, intake time etc.
  • Consider the method of application, as the Avian Coronavirus is an encapsulated virus, which is not resistant in the environment, and another point to consider is: the infection generally starts in the upper respiratory tract, so the ideal method of application is by spray or eye-drops.

Conclusions

For the IB vaccination programme, it is very important to know the strains present in the region and to choose the right vaccines, as the protectotype often includes one Massachusetts strain and one variant strain for example: 793/b or QX and a Massachusetts strain, some points are important to consider:

  • The diagnosis of Infectious Bronchitis is complex and the use of different methods, such as molecular diagnostic (PCR/ Sequencing), serology etc. is important.
  • The Massachusetts strain is normally present in all vaccination programmes and it is key for the protectotype.
  • The ideal method of application is by spray or eyedrop.

If you are interested in obtaining more information about BRONIPRA®1, H-120 strain, a live Massachusetts strain with a minimum titre of 10 3.0, check out the link below.

Highly concentrated inactivated Massachusetts strain Infectious Bronchitis vaccines to consider are the BRONIPRA® ND, an inactivated IB vaccine with Newcastle and the BRONIPRA® ND IBD, inactivated Infectious Bronchitis (IB) vaccine with Newcastle Disease (ND) and Infectious Bursal Disease (IBD) vaccine to provide long term protection.

You can access more detailed information about the vaccines by clicking on the links below:

BRONIPRA® 1

BRONIPRA® ND

BRONIPRA® ND IBD

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

His Apple Watch warned of an irregular heart rate. Turns out he was having a heart attack | Globalnews.ca - Global News Toronto

Image
A Nova Scotia man is thanking a digital watch for saving his life. Travis Chalmers, of Elmsdale, N.S., said he was outside playing road hockey with his son when he suddenly experienced a "warm sensation" in his chest area and a splitting headache. "I just thought it was a flu or cold coming on and my seasonal allergies had been kicking in. I thought it was flu-like symptoms and shrugged it off," he said. But to Chalmers' surprise, an otherwise laidback afternoon eventually took a scary turn when he glanced at his wrist. A notification from his Apple Watch led him to discover he was experiencing a heart attack. "About a half hour later, I'm laying down with my daughter and my heart rate is still beating out of my chest," he continued, adding that he monitored his heart rate on his Apple Watch for the next few hours. The watch indicated that he was experiencing atrial fibrillation, a rapid heart rhythm that can increase the ris...
Read more

“Opioids in America, Part 3: The other side of the crisis - Greeley Tribune” plus 1 more

Image
“Opioids in America, Part 3: The other side of the crisis - Greeley Tribune” plus 1 more Opioids in America, Part 3: The other side of the crisis - Greeley Tribune Posted: 31 Oct 2020 04:20 PM PDT Editor's Note: This is Part 3 of a three-part series looking into the opioid epidemic across the U.S., rehabilitation options in Weld County and stories from people who have overcome or are currently fighting addiction to opioids. Like many things, there's another side to the opioid crisis. While the addiction to opioids is a problem that needs to be addressed, people who are using the drugs exclusively as prescribed — and who still truly need it from a medical perspective — have been swept up in what some have seen as government's knee-jerk reaction to the crisis. In having their ability limited to get the drugs they need in order to function, many of these patients are left suffering debilitating pain. Richard Mark VanWormer w...
Read more

“A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed. - The New York Times” plus 1 more

Image
“A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed. - The New York Times” plus 1 more A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed. - The New York Times Posted: 12 Dec 2019 11:25 AM PST It was chest pain that brought the 34-year-old woman to the emergency room at Montefiore Medical Center in the Bronx. She'd been coughing for days, but that morning the pain was so bad she was worried that it had turned into pneumonia. She tried to tough it out, but when it was no better by the end of the day, she decided to go to the E.R. It took a few hours, but finally the physician assistant caring for her in the E.R. brought some good news. She didn't have pneumonia; she didn't have a clot in her lungs. This was just muscle strain from coughing. The year before, she was told she had asthma. She was given inhalers to stop the coughing and wheezing, but they didn't seem to do much. So she didn'...
Read more